Immunization clinical trials

Explore recruiting immunization clinical trials.

Recruiting immunization studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Immunization trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Implementation RSV Immunization Study (IRIS)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01).

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Phase II, single-blind, randomized, controlled study to evaluate the immunogenicity and safety of a measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children 4 to 6 years of age

Latvia, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A parallel-group prevention, Phase II, partially blinded, multi-stage study to investigate the immunogenicity and safety of Pentavalent Meningococcal ABCYW Vaccine formulations compared with licensed meningococcal vaccines when administered alone in healthy children (2 to 9 years of age) or concomitantly with routine pediatric vaccines in toddlers (12 to 15 months of age) and infants (2 months of age).

Poland, Finland, Spain, Denmark, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Late immunity following single immunization with GA2 sporozoites (GACHA)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Durvalumab Monotherapy or Durvalumab in Combination with Tremelimumab in Pediatric Patients with Advanced Solid Tumors and Hematological Malignancies

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Immunization trials by city

Immunization in Toronto Immunization in Vancouver Immunization in Montreal Immunization in Calgary Immunization in Edmonton Immunization in Ottawa Immunization in Winnipeg Immunization in Quebec City Immunization in Hamilton Immunization in Kitchener Immunization in London Immunization in Halifax Immunization in New York Immunization in Los Angeles Immunization in Chicago Immunization in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease